[1]
“ Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant ”, Braz. J. Pharm. Sci., vol. 48, no. 4, pp. 621–628, Dec. 2012, doi: 10.1590/S1984-82502012000400005.